USPTO serial 79299604
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of oncology, rheumatoid arthritis, multiple sclerosis, cardiovascular, respiratory, allergy, inflammatory, autoimmune and degenerative, COVID-19 diseases ; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncology, rheumatoid arthritis, multiple sclerosis, cardiovascular, respiratory, allergy, inflammatory, autoimmune and degenerative, COVID-19 diseases ; biological preparations for medical purposes for the treatment of oncology, rheumatoid arthritis, multiple sclerosis, cardiovascular, respiratory, allergy, inflammatory, autoimmune and degenerative, COVID-19 diseases ; biological tissue cultures for medical purposes ; albuminous preparations for medical purposes, namely, albumin dietary supplements ; chemical preparations for medical purposes, namely for the treatment of oncology, rheumatoid arthritis, multiple sclerosis, cardiovascular, respiratory, allergy, inflammatory, autoimmune and degenerative, COVID-19 diseases | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of manufacture processes for biotechnology products; technological consultation in the field of development of manufacturing processes for biotechnology products | ACTIVE | — |
| 044 | Medical services ; midwife services ; alternative medicine services ; in vitro fertilization services ; chiropractic services ; physiotherapy ; occupational therapy services ; human tissue bank services ; hospital services ; rental of medical equipment ; medical advice for individuals with disabilities ; medical clinic services ; medical analysis services for diagnostic and treatment purposes provided by medical laboratories ; medical assistance ; opticians' services ; plastic surgery ; services of a psychologist ; convalescent home services ; preparation of prescriptions by pharmacists ; rehabilitation of substance abuse patients ; nursing, medical ; health centre services ; health counselling ; medical screening ; health care ; telemedicine services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 11, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 11, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 1, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 1, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 16, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 16, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 27, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 5, 2021 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 19, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 17, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 17, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 17, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 17, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 16, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 17, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 17, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 17, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 16, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 11, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 10, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |